During the past decade, Baylor Metabolic Research Unit (MRU) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baylor Metabolic Research Unit (MRU)" are "Erythrocyte Glutathione Deficiency" (2 trials), "Aging" (1 trials), "HIV Infection" (1 trials) and "Muscle Weakness" (1 trials). Many other conditions were trialed in "Baylor Metabolic Research Unit (MRU)" in a lesser frequency.

Most popular intervention types in "Baylor Metabolic Research Unit (MRU)" are "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cysteine (as n-acetylcysteine) and Glycine" (1 trials) and "GlyNAC (combination of glycine and n-acetylcysteine)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Metabolic Research Unit (MRU)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Metabolic Research Unit (MRU)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Baylor Metabolic Research Unit (MRU), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Metabolic Research Unit (MRU), 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".